Accenture Plc (ACN): ACN new 52 week high

Monksdream · 2024-01-15T19:23:57.3570000Z

ACN new 52 week high https://investorshub.advfn.com/uimage/uploads/2024/1/15/ub[jdIMG_4069.gif

Play Episode

6min

Proactive - Interviews for investors

Leading Edge Materials to reapply for strategic project status as Norra Kärr development advances

Leading Edge Materials CEO Kurt Budge joined Steve Darling from Proactive provided an update on the company’s Norra Kärr Heavy Rare Earth Elements Project, including a decision on its application for Strategic Project status under the EU Critical Raw Materials Act. While Norra Kärr was not included in the EU’s first list of Strategic Projects, the company remains committed to the initiative and will reapply once the next call for applications is announced. Despite this outcome, Leading Edge Materials has continued to make significant progress at Norra Kärr. Since submitting its application in August 2024, the company has reached a key milestone by submitting a new application for an Exploitation Concession—a 25-year mining lease—and remains focused on exploring innovative pathways for early and sustainable production. Budge also shared updates on the company’s Rapid Development Plan, which is designed to accelerate the extraction process and shorten the timeline to production of heavy rare earth element (HREE) concentrate and nepheline syenite. A key aspect of this strategy is a phased development approach, starting with a small-scale operation to enable early deposit access, generate initial revenue from nepheline syenite sales, and stockpile HREE concentrate for future processing. This approach is intended to minimize both financial risk and environmental impact while establishing a strong foundation for long-term operations. Budge also discussed ongoing testwork on nepheline syenite and aegirine, which is focused on mineralogy, chemical composition, and leachate chemistry. These findings will be crucial in assessing market opportunities, including potential demand and pricing scenarios. The company is actively exploring higher-value markets, such as functional filler products, where prices have ranged between US$100 and US$500 per tonne. Given that nepheline syenite contributed 11% of total revenue in the 2021 Preliminary Economic Assessment (PEA), the compa

Proactive - Interviews for investors

Founders Metals extends high-grade gold discovery at Van Gogh with promising drill results

Founders Metals CEO Colin Paget joined Steve Darling from Proactive to discuss the latest assay results from preliminary drilling at Van Gogh, the newest high-grade gold discovery at the company’s Antino Gold Project in southeastern Suriname. Recent drilling returned an impressive 72.0 metres (m) of 2.29 grams per tonne (g/t) gold (Au), extending mineralization to approximately 200.0 m vertical depth. This follows the previously reported 28.5 m of 7.12 g/t Au interval from just 18 metres downhole. Paget emphasized that gold mineralization extends from the surface, through the saprolite zone, and into fresh rock at depth. Notably, Van Gogh represents a completely original discovery with no current or historical artisanal mining within 1.5 km of the target area, highlighting its untapped potential. Encouraged by continued success at both Van Gogh and Da Vinci, Founders Metals is prioritizing exploration in new, high-potential areas. Up to 50% of the company's 2025 drill program will be allocated to these high-priority targets, reinforcing its commitment to expanding the Antino Gold Project. Additionally, a fifth diamond drill is expected to be operational by mid-year, further accelerating exploration efforts. #proactiveinvestors #foundersmetalsinc #tsxv #fdr #otc #fdmif #vangogh #davinci #Antino Gold Project

Proactive - Interviews for investors

Acuity Risk Management CEO on cybersecurity, partnerships & growth

Acuity RM Group Plc (AIM:ACRM) CEO David Rajakovich talked with Proactive's Stephen Gunnion about the company's role in the cyber GRC (governance, risk, and compliance) space. Unlike traditional cybersecurity providers, Acuity focuses on real-time risk assessment through its flagship product, STREAM. Rajakovich explained that STREAM functions as a command centre, integrating external data sources to offer a comprehensive view of an organisation's security posture. Rajakovich, who recently took over as CEO, shared his background in scaling businesses, particularly his experience at Skill Dynamics. He highlighted Acuity’s strong presence in government and defence, as well as its growing footprint in financial services and highly regulated industries like pharmaceuticals. The discussion also covered Acuity’s recent acquisition of Rizikon from Crossword Cybersecurity. Rajakovich emphasised that the acquisition was driven by the opportunity to expand Acuity’s customer base, rather than the software itself. Many Rizikon customers are now transitioning to STREAM, benefiting from its broader capabilities. Looking ahead, Rajakovich hinted at upcoming partnerships, particularly within the government and defence sectors. He also outlined Acuity’s two-pronged growth strategy: expanding its mid-market reach through product-led growth and leveraging strategic partnerships to access customers earlier in their cybersecurity journey. With a refined go-to-market strategy and a focus on scalability, Acuity Risk Management is positioning itself for significant growth in the coming years. For more interviews with industry leaders, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for future updates. #CyberSecurity #RiskManagement #AcuityRisk #GRC #STREAM #CyberGRC #DataProtection #InfoSec #RiskAssessment #CyberThreats #RegulatoryCompliance #ISO27001 #SOC2 #CyberDefense #BusinessSecurity

Proactive - Interviews for investors

Zero Candida begins trading on OTCQB, advances AI-driven women’s health solutions

Zero Candida Co-Founder and CEO Eli Ben-Haroosh joined Steve Darling from Proactive to announce that the company’s common shares are now trading on the OTCQB Venture Market under the ticker "ZCTFF", alongside its existing listings on the TSX Venture Exchange and Frankfurt Stock Exchange. Ben-Haroosh emphasized that this milestone expands Zero Candida’s market presence, enhances strategic partnerships, and broadens the company’s investor base to support its AI-driven medical technology innovations. Zero Candida is pioneering a novel, non-drug treatment for Vulvo-Vaginal Candidiasis (VVC)—a condition affecting approximately 75% of women globally, with rising resistance to conventional antifungal treatments. The company is developing a tampon-like medical device that utilizes artificial intelligence and therapeutic blue light at a precise wavelength and intensity to eradicate Candida fungus. Early proof-of-concept (POC) studies have demonstrated an impressive 99.999% success rate in treating infections. With drug-resistant cases of recurrent VVC on the rise, Zero Candida’s innovative approach offers a groundbreaking alternative to existing treatments. Zero Candida has completed its preclinical trials with what Haroosh said was “100% safety,” and is preparing for clinical trials by the end of 2025, with market entry targeted after 2026 following FDA approval. #proactiveinvestors #zerocandida #tsxv #zct #WomensHealth #CandidaTreatment #MedicalDevice #Telemedicine #AIinHealthcare #NonDrugTherapy #OTCQB #HealthcareInnovation #FungalInfection

Followers	290
Posts	59723
Boards Moderated	4
Alias Born	08/29/2007

Volume:	2,378,272
Day Range:	303.8441 - 310.07
Bid:
Ask:
Last Trade Time:	7:57:44 PM EDT
Total Trades:	47,123

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

ACN Detailed Quote

Recent ACN News

More ACN News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ACN News

Go Ad-Free